Enhanced Investments - Financial Portal

General information

Country: UNITED STATES

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Website: bms.com

Bad financial results growth rate -33.8% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (21.5%)
Dividend yield for the last twelve months 6.4%
Free cash flow yield 10.7% (LTM)
Share price is 0.7% higher than minimum and 45.5% lower than maximum for the last 3 years
The company is undervalued by EV / LTM EBITDA multiple compared to target level (10.3x vs
)
Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: BMY

Share price, USD: (+0.7%)44.229

year average price 56.22

year start price 66.64 2023-05-03

max close price 69.08 2023-05-11

min close price 43.94 2024-04-30

current price 43.94 2024-05-01

Common stocks: 2 111 517 922

Dividend Yield: 6.4%

FCF Yield LTM: 10.7%

EV / LTM EBITDA: 10.3x

EV / EBITDA annualized: 19.3x

Last revenue growth (y/y): -3.5%

Last growth of EBITDA (y/y): -64.1%

Historical revenue growth: 27.6%

Historical growth of EBITDA: 15.3%

Target EV / EBITDA (hist percentile):

Fundamental value created in LTM:

EV / LTM EBITDA mutiple calculation

Market Cap ($m): 93 390

Net Debt ($m): 31 427

EV (Enterprise Value): 124 817

EBITDA LTM ($m): 12 133

EV / LTM EBITDA: 10.3x

Price to Book: 5.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News

2024-04-30Zacks Investment Research

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

2024-04-29CNBC

Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations

2024-04-29Reuters

J&J, Bristol Myers lose challenges to US drug price negotiation program

2024-04-27Seeking Alpha

2 Very Cheap Turnarounds Yielding Up To 7%

2024-04-25Zacks Investment Research

Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

2024-04-25Zacks Investment Research

Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat

2024-04-25The Motley Fool

Why Bristol Myers Squibb Stock Is Sinking Today

2024-04-25InvestorPlace

Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts

2024-04-25Zacks Investment Research

Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

2024-04-25Barrons

Bristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cuts

More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.